Biocorp Production Past Earnings Performance

Past criteria checks 0/6

Biocorp Production has been growing earnings at an average annual rate of 42.7%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 19.7% per year.

Key information

42.7%

Earnings growth rate

45.5%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate19.7%
Return on equity-86.8%
Net Margin-16.7%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Dec 08
Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Jun 26
What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 11
Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Mar 04
What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Jan 10
Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Nov 18
What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Revenue & Expenses Breakdown
Beta

How Biocorp Production makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALCOR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2313-260
31 Mar 2312-160
31 Dec 2212-160
30 Sep 2211-160
30 Jun 2210-160
31 Mar 2210060
31 Dec 2110050
30 Sep 219-150
30 Jun 218-250
31 Mar 218-150
31 Dec 208-150
30 Sep 208-140
30 Jun 207-140
31 Mar 208040
31 Dec 198140
30 Sep 198040
30 Jun 197-140
31 Mar 196-340
31 Dec 184-540
30 Sep 184-640
30 Jun 183-840
31 Mar 183-840
31 Dec 172-840
30 Sep 172-640
30 Jun 172-540
31 Mar 173-540
31 Dec 163-440
30 Sep 163-430
30 Jun 163-430
31 Mar 163-230
31 Dec 153-130
31 Dec 142020
31 Dec 132010
31 Dec 122010

Quality Earnings: ALCOR is currently unprofitable.

Growing Profit Margin: ALCOR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALCOR is unprofitable, but has reduced losses over the past 5 years at a rate of 42.7% per year.

Accelerating Growth: Unable to compare ALCOR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALCOR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.5%).


Return on Equity

High ROE: ALCOR has a negative Return on Equity (-86.82%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.